Cargando…

Risk assessment for COVID-19 pandemic in Taiwan

BACKGROUND AND OBJECTIVES: Event-based surveillance and rapid risk assessment for acute public health events are essential in emerging infectious disease control. Since detecting the unusual signal in Wuhan in December 2019, Taiwan has been aligning risk management to policy planning via conducting...

Descripción completa

Detalles Bibliográficos
Autores principales: Jian, Shu-Wan, Kao, Chien-Tse, Chang, Yi-Chia, Chen, Pi-Fang, Liu, Ding-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826118/
https://www.ncbi.nlm.nih.gov/pubmed/33486014
http://dx.doi.org/10.1016/j.ijid.2021.01.042
_version_ 1783640466255773696
author Jian, Shu-Wan
Kao, Chien-Tse
Chang, Yi-Chia
Chen, Pi-Fang
Liu, Ding-Ping
author_facet Jian, Shu-Wan
Kao, Chien-Tse
Chang, Yi-Chia
Chen, Pi-Fang
Liu, Ding-Ping
author_sort Jian, Shu-Wan
collection PubMed
description BACKGROUND AND OBJECTIVES: Event-based surveillance and rapid risk assessment for acute public health events are essential in emerging infectious disease control. Since detecting the unusual signal in Wuhan in December 2019, Taiwan has been aligning risk management to policy planning via conducting regular risk assessments to combat the coronavirus disease 2019 (COVID-19). This article aims to provide some insights into Taiwan's experiences and corresponding actions for the outbreak. RESULTS: The COVID-19 risk level in Taiwan was raised to “moderate-to-high” in mid-January 2020 when neighboring countries had reported cases and the human-to-human transmission became obvious. The risk level became “high” on 24 January due to China's escalating epidemic situation and imposed a lockdown in Wuhan. We learned that the commander recognized the importance of risk assessments and considered advice from the experts was crucial in making the correct decision at the early stage of the crisis. CONCLUSIONS: Given the surge of COVID-19 cases globally, understanding the evidence-driven mobilizations via detailed risk assessments in Taiwan may be an example worth considering for other countries. We believe that strengthening a global epidemic intelligence network and sharing information in a timely and transparent manner are essential for confronting new challenges of COVID-19 and other emerging infectious diseases.
format Online
Article
Text
id pubmed-7826118
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
record_format MEDLINE/PubMed
spelling pubmed-78261182021-01-25 Risk assessment for COVID-19 pandemic in Taiwan Jian, Shu-Wan Kao, Chien-Tse Chang, Yi-Chia Chen, Pi-Fang Liu, Ding-Ping Int J Infect Dis Perspective BACKGROUND AND OBJECTIVES: Event-based surveillance and rapid risk assessment for acute public health events are essential in emerging infectious disease control. Since detecting the unusual signal in Wuhan in December 2019, Taiwan has been aligning risk management to policy planning via conducting regular risk assessments to combat the coronavirus disease 2019 (COVID-19). This article aims to provide some insights into Taiwan's experiences and corresponding actions for the outbreak. RESULTS: The COVID-19 risk level in Taiwan was raised to “moderate-to-high” in mid-January 2020 when neighboring countries had reported cases and the human-to-human transmission became obvious. The risk level became “high” on 24 January due to China's escalating epidemic situation and imposed a lockdown in Wuhan. We learned that the commander recognized the importance of risk assessments and considered advice from the experts was crucial in making the correct decision at the early stage of the crisis. CONCLUSIONS: Given the surge of COVID-19 cases globally, understanding the evidence-driven mobilizations via detailed risk assessments in Taiwan may be an example worth considering for other countries. We believe that strengthening a global epidemic intelligence network and sharing information in a timely and transparent manner are essential for confronting new challenges of COVID-19 and other emerging infectious diseases. The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021-03 2021-01-21 /pmc/articles/PMC7826118/ /pubmed/33486014 http://dx.doi.org/10.1016/j.ijid.2021.01.042 Text en © 2021 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Perspective
Jian, Shu-Wan
Kao, Chien-Tse
Chang, Yi-Chia
Chen, Pi-Fang
Liu, Ding-Ping
Risk assessment for COVID-19 pandemic in Taiwan
title Risk assessment for COVID-19 pandemic in Taiwan
title_full Risk assessment for COVID-19 pandemic in Taiwan
title_fullStr Risk assessment for COVID-19 pandemic in Taiwan
title_full_unstemmed Risk assessment for COVID-19 pandemic in Taiwan
title_short Risk assessment for COVID-19 pandemic in Taiwan
title_sort risk assessment for covid-19 pandemic in taiwan
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826118/
https://www.ncbi.nlm.nih.gov/pubmed/33486014
http://dx.doi.org/10.1016/j.ijid.2021.01.042
work_keys_str_mv AT jianshuwan riskassessmentforcovid19pandemicintaiwan
AT kaochientse riskassessmentforcovid19pandemicintaiwan
AT changyichia riskassessmentforcovid19pandemicintaiwan
AT chenpifang riskassessmentforcovid19pandemicintaiwan
AT liudingping riskassessmentforcovid19pandemicintaiwan